E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer
- PMID: 12636887
- DOI: 10.3816/CBC.2003.n.007
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
